LGALS3 and Huntington disease: Using two inhibitors (Bay11 and Ro106) of the NFκB pathway, we demonstrated that NFκB plays a critical role in the up-regulation of Gal3 in HD microglia (Fig. 3a, Supplementary Fig. 4).